Document is current
Any future updates will be listed below
-
Authors
Nagarajan, Chandramouli
Jen, Wei-Ying https://orcid.org/0000-0002-9339-3362
Ooi, Melissa https://orcid.org/0000-0002-7392-0655
De Mel, Sanjay https://orcid.org/0000-0002-8881-3537
Soekojo, Cinnie
Yoon, Sung Soo https://orcid.org/0000-0002-2302-3825
Tan, Melinda
Chen, Yunxin https://orcid.org/0000-0001-9039-3474
Li, Xinhua
Pokharkar, Yogesh
Tham, Shi Ning
Hashim, Nur Shahidah Binte
Awasthi, Neha
Burkill, Sarah M.
Durie, Brian
Chng, Wee Joo https://orcid.org/0000-0003-2578-8335
-
Funding
Funding for this research was provided by:
Janssen Pharmaceuticals (N/A)
- License Information
-
More Information
Article History
Received: 21 August 2024
Revised: 8 April 2025
Accepted: 23 April 2025
First Online: 17 June 2025
Competing interests
: The authors declare no competing interests.
: All patients provided informed consent before trial entry. The trial was approved by institutional IRBs of all participating centres. The trial was conducted in accordance with the principles of the Declaration of Helsinki and the International Conference on Harmonisation Good Clinical Practice guidelines.
